Evaluation of the Contribution of Homologous Recombination in DNA Double-Strand Break Repair in Human Fibroblasts after Exposure to Low and Intermediate Doses of X-ray Radiation


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Abstract—Studies of the changes in the number of γH2AX foci (a DNA double-strand break protein-marker), and Rad51 foci (a key homologous recombination protein) were conducted on human fibroblast cultures during the 24 hours after exposure to low (80 mGy) and intermediate (250 and 1000 mGy) doses of X-ray irradiation. Based this data, exponential curves that approximated the experimental values were constructed, and the characteristic lifetimes of the γH2AX and Rad51 foci were evaluated using the method of least squares. The ratio of the areas under the curves of changes in the number of Rad51 and γH2AX foci, calculated by the trapezium method, divided by the ratio of the characteristic lifetimes of the Rad51 and H2AX foci was used to evaluate the contribution of homologous recombination in DNA double-strand break repair. It was shown that the contribution of homologous recombination in DNA double-strand break repair during the 24 hours after exposure to 80, 250 and 1000 mGy was approximately 16, 12 and 9% respectively. Thus, the relative contribution of homologous recombination in the DNA double-strand break repair after exposure to a low dose of X-ray irradiation was approximately 1.5 times higher than that after exposure to intermediate doses. Our results suggest that DNA double-strand break repair induced after exposure to 80 mGy of X-ray irradiation is more accurate than after exposure to 250 and 1000 mGy.

Авторлар туралы

A. Grekhova

Emanuel Institute of Biochemical Physics, Russian Academy of Sciences; State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Хат алмасуға жауапты Автор.
Email: Annagrekhova1@gmail.com
Ресей, Moscow, 119991; Moscow, 123182; Moscow, 117977

M. Pustovalova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: Annagrekhova1@gmail.com
Ресей, Moscow, 123182; Moscow, 117977

P. Eremin

Russian Scientific Center of Medical Rehabilitation and Health Resort of the Ministry of Public Health

Email: Annagrekhova1@gmail.com
Ресей, Moscow, 121099

I. Ozerov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: Annagrekhova1@gmail.com
Ресей, Moscow, 123182

O. Maksimova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: Annagrekhova1@gmail.com
Ресей, Moscow, 123182

A. Gordeev

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: Annagrekhova1@gmail.com
Ресей, Moscow, 123182

N. Vorobyeva

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: Annagrekhova1@gmail.com
Ресей, Moscow, 123182; Moscow, 117977

A. Osipov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Хат алмасуға жауапты Автор.
Email: Annagrekhova1@gmail.com
Ресей, Moscow, 123182; Moscow, 117977

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2019